Genitourinary Carcinoma

Meet our Speakers

We've gathered some of the top experts in the field to discuss this topic. With years of experience between them, they're well-equipped to offer invaluable insights and perspectives.

Prof. Oliver Dorigo

Department of Obstetrics and Gynecology, Stanford University, Stanford, California, USA

Dr Giuseppe Luigi Banna

Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Prof. Jianyu Rao

University of California at Los Angeles, Los Angeles CA, USA

Prof. CI Weimin

Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China

Talks

Single-cell atlases link macrophages and CD8+ T-cell in immunotherapy response in urothelial carcinoma

06 May 2023, 12:00 PM

Scientific Session H: New Therapeutic Solutions in Gynecological Cancers

06 May 2023, 04:00 PM

Prognostic models for immunotherapy of lung and urology cancers

07 May 2023, 08:00 AM

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Book My Place